We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Trinity Biotech plc (TRIB) ADR Each Representing 20 Ord Shares SPON

Sell:$2.86 Buy:$2.90 Change: $0.05 (1.69%)
NASDAQ:1.03%
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Sell:$2.86
Buy:$2.90
Change: $0.05 (1.69%)
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Sell:$2.86
Buy:$2.90
Change: $0.05 (1.69%)
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Contact details

Address:
Ida Business Park
Bray, Co Wicklow, Ireland
BRAY
18
Ireland
Telephone:
+353 (1) 2769800
Website:
https://www.trinitybiotech.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TRIB
ISIN:
US8964385046
Market cap:
$29.72 million
Shares in issue:
30.57 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • John Gillard
    President, Chief Executive Officer, Executive Director
  • Ronan O'caoimh
    Founder, Executive Director
  • Louise Tallon
    Chief Financial Officer, Chief Accounting Officer
  • Des Fitzgerald
    Interim Chief Financial Officer
  • Gary Keating
    Chief Technology Officer
  • Simon Dunne
    Chief Accounting Officer
  • Eibhlin Kelly
    Chief Information Officer
  • Micheal Roche
    Vice President - Global Health
  • Ian Wells
    Vice President - Quality and Regulatory Affairs
  • James Walsh
    Executive Director - Business Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.